CARBIDOPA TABLETS
Manufacturer: Oceanside Pharmaceuticals
Score: 144.0
Carbidopa is a drug used in the treatment of Parkinson's disease, postencephalitic parkinsonism, and symptomatic parkinsonism. It is often administered with levodopa to reduce the peripheral effects of levodopa, such as nausea and vomiting, and to increase the bioavailability of levodopa in the brain. The optimal daily dosage of carbidopa must be determined by careful titration, and it is recommended to start with a low dose and gradually increase as needed. Carbidopa has several contraindications, including known hypersensitivity to any component of the drug, nonselective monoamine oxidase inhibitors, and narrow-angle glaucoma. The most common adverse reactions include dyskinesias, nausea, and psychotic episodes. Carbidopa should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, and it is not recommended for use in pediatric patients or nursing mothers.
Carbidopa has no antiparkinsonian effect when given alone and should not be used without levodopa or carbidopa-levodopa combination products.
Dosage of carbidopa may be adjusted by adding or omitting one-half or one tablet a day.
25 mg three or four times a day
Not recommended for pediatric patients